EUVIMEDEUVIMED entdecken
Crossref

Drug Repurposing and Screening for Multiple Sclerosis Targeting Microglia and Macrophages

Nandi Bao, Jing Liu, Heran Wang, Lei Xing, Zhonghui Xie, Chuanbin Liu, Shaowei Jin, Jianjun Jia, Minghua Zhang, Jiao Fan

Molecular Neurobiology · 2025

DOI: 10.1007/s12035-024-04602-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Nandi Bao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Cardiology, the Sixth Medical Center of PLA General Hospital, Beijing, 100048, China. Hauptthemen laut MEDLINE: Microglia, Drug Repositioning, Multiple Sclerosis, Macrophages. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Chinese PLA General Hospital, Beijing Nova Program Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microglia/macrophages (MG/Mφ) play a central role in the pathogenesis of multiple sclerosis (MS). However, the intricacies of the immunomodulatory microenvironment in MS, particularly the heterogeneity and regulatory mechanisms of MG/Mφ subpopulations, remain elusive. The commonly used treatment options for MS have several drawbacks, such as significant side effects and uncertain efficacy. The exploration of developing new drugs targeting MG/Mφ for the treatment of MS remains to be investigated. We identified three distinct subpopulations of MG/Mφ, among which MG/Mφ_3 significantly increased as the experimental autoimmune encephalomyelitis (EAE) progressed. Ifenprodil and RO-25-6981 demonstrated notable inhibition of inflammatory factor expression, accompanied by reduced cytotoxicity. The interaction modes of these compounds with the common binding pocket in the GluN1b-GluN2B amino terminal domain heterodimer were elucidated. Virtual docking, based on the N-methyl-D-aspartate (NMDA) receptor, showed that homo-skeleton compounds of ifenprodil potentially exhibit low binding free energy with the receptor, including eliprodil and volinanserin. In vitro cell models corroborated the effective inhibition of inflammatory factor expression and minimal cytotoxicity of eliprodil and volinanserin. CoMFA (standard error of estimate = 0.378, R2 = 0.928, F values = 241.255, Prob. of R2 = 0) and topomer CoMFA (q2 = 0.553, q2 stderr = 0.77, intercept = - 1.48, r2 = 0.908, r2 stderr = 0.35) were established based on the inhibitors of NMDA receptor. The contour maps of CoMFA and topomer CoMFA models give structural information to improve the inhibitory function. This study underscores the involvement of MG/Mφ in inflammatory pathways during MS progression and offers promising compound candidates for MS therapy targeting MG/Mφ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaDrug RepositioningMultiple SclerosisMacrophagesAnimalsEncephalomyelitis, Autoimmune, ExperimentalMice, Inbred C57BLMolecular Docking SimulationReceptors, N-Methyl-D-AspartateMiceDrug Evaluation, PreclinicalFemaleHumansPiperidines

Stichwörter der Autor:innen

Drug repositioning analysisMacrophageMicrogliaMultiple sclerosisNMDA receptor inhibitors

Substanzen

Receptors, N-Methyl-D-AspartatePiperidinesifenprodil

Autor:innen und Institutionen

  • Senior Department of Cardiology, the Sixth Medical Center of PLA General Hospital, Beijing, 100048, China.
  • Institute of Geriatrics, National Clinical Research Center of Geriatrics Disease, the Second Medical Center of PLA General Hospital, Beijing, 100853, China.
  • Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
  • National Supercomputing Shenzhen Center, Shenzhen, 518052, China.
  • Institute of Geriatrics, National Clinical Research Center of Geriatrics Disease, the Second Medical Center of PLA General Hospital, Beijing, 100853, China. jiajianjun301@126.com.
  • Medical Supplies Center of PLA General Hospital, Beijing, 100853, China. zmreformer@126.com.

Förderung

  • Chinese PLA General Hospital
  • Beijing Nova Program Grant

Zitieren

APA

Bao, N., Liu, J., Wang, H., Xing, L., Xie, Z., Liu, C., Jin, S., Jia, J., Zhang, M., & Fan, J. (2025). Drug Repurposing and Screening for Multiple Sclerosis Targeting Microglia and Macrophages. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04602-w

Vancouver

Bao N, Liu J, Wang H, Xing L, Xie Z, Liu C, et al. Drug Repurposing and Screening for Multiple Sclerosis Targeting Microglia and Macrophages. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04602-w

BibTeX
@article{Bao2025,
  author = {Bao, Nandi and Liu, Jing and Wang, Heran and Xing, Lei and Xie, Zhonghui and Liu, Chuanbin and Jin, Shaowei and Jia, Jianjun and Zhang, Minghua and Fan, Jiao},
  title = {Drug Repurposing and Screening for Multiple Sclerosis Targeting Microglia and Macrophages},
  journal = {Molecular Neurobiology},
  year = {2025},
  doi = {10.1007/s12035-024-04602-w}
}
Kostenlos starten →